Project Grant P20GM156674

Award Date 6/1/25
Completion Date 2/28/30
Dollars Obligated $2.6M
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Delaware, USA
Similar Awards
The National Institute of General Medical Sciences (NIGMS) awarded a $1,542,717 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to the University of Delaware. The grant funding will support a research project titled "Deciphering Protein Ubiquitination with Chemical Biology Tools - Ubiquitination as a Reversible Post-Translational Modification is Essential to a Broad Range of Cellular Processes in Humans." The project aims to investigate the recognition and...
The National Science Foundation awarded a $365,567 Project Grant to the University of Delaware under the Biological Sciences federal grant program (CFDA 47.074). The funding will support the acquisition of a Sartorius Biolayer Interferometer Octet RH16 instrument for label-free detection of biomolecular interactions. The instrument will be used broadly in research and undergraduate training programs across multiple campuses, including the University of Delaware and surrounding Primarily...
The National Science Foundation Division of Molecular and Cellular Biosciences awarded a $738,612 Project Grant to the University of Delaware under the Biological Sciences federal grant program (CFDA 47.074) for the period of August 1, 2021 through July 31, 2025. The grant funds research into membrane fluidity and its fundamental and functional roles. The University of Delaware will conduct theoretical and computational research, while the University of California San Diego will receive a...
The National Science Foundation (NSF) has awarded a $1,000,000 Project Grant under the Biological Sciences (CFDA 47.074) program to the University of Delaware. The objective of this 3-year grant, which runs from August 2024 to July 2027, is to develop a new strategy for real-time metabolite sensing and metabolon formation using biomolecular condensates. The research aims to create synthetic ligand-responsive transcription factor-based protein devices that can translate metabolite-induced DNA...
This federal Project Grant award under the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) will provide $725,864 to the University of Delaware from August 15, 2024 to June 30, 2029 to conduct research on the signaling, sensing, and enzymatic roles of disordered selenoproteins. The research will focus on the function of the endoplasmic reticulum (ER)-bound membrane proteins selenoprotein K (SELENOK) and selenoprotein S...
This $7,250,000 federal Project Grant award, funded by the National Institute of Standards and Technology (NIST) under the Congressionally-Identified Projects program (CFDA 11.617), will enable the University of Delaware to procure biopharmaceutical manufacturing equipment at the pilot/clinical scale. The purpose is to establish a testbed for benchmarking current and future biopharmaceutical manufacturing innovations, as well as to support workforce development training activities, within the...
This $505,135 federal Project Grant was awarded by the Office of Naval Research (ONR) under the Basic and Applied Scientific Research program (CFDA 12.300) to the University of Delaware. The grant supports high-resolution mass spectrometry research and education to advance biocontainment capabilities. The award period runs from January 1, 2025 to December 31, 2025. As a prime recipient and sub-awardee, the University of Delaware has a strong track record of delivering sophisticated research...
The University of Delaware received a $1,106,498 Project Grant award from the National Science Foundation Division of Integrative Organismal Systems. The grant was awarded under the Biological Sciences program (CFDA 47.074) on July 1, 2021 for a period of performance through June 30, 2024. The grant will fund research examining the role of plasmodesmata and chloroplasts in integrative defense signaling. As the stated goal of the Biological Sciences program is to advance the field and...
The National Institute of General Medical Sciences (NIGMS) awarded a $382,136 Project Grant under the Biomedical Research and Research Training Program (CFDA 93.859) to the University of Maryland, College Park. The 5-year grant, effective May 1, 2025 through March 31, 2030, supports research to define engineering principles for designing programmable bioengineered multicellular structures (probioms) in prokaryotic cells. The goal is to develop a framework for engineering probiotic-based...
This federal Project Grant award of $820,000 from the National Science Foundation (NSF) Biological Sciences program (CFDA 47.074) supports research conducted by the University of Delaware to control the spatial arrangement and function of synthetic microbial communities. The key products and services to be delivered under this 3-year award include: Repurposing innovative biological containment tools to direct the self-assembly of specific microbes within a larger synthetic microbial community....

This $2,566,480 federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) will fund the "Center for Biomedical Research Excellence in Multiscale Biomolecular Sensing (MBS) - Overall Plan" at the University of Delaware. The 5-year project aims to accelerate fundamental research on multi-scale sensing of biochemical and biological processes that impact a wide range of human diseases. Key objectives include establishing a Multiscale Biomolecular Sensing Research Core, providing mentoring and retention programs for faculty, and supporting synergistic and multidisciplinary research projects. Completion of this phase will position Delaware as a leading research hub in this domain, enabling deeper understanding of human disease states and development of novel treatments and technologies to improve human health.

Generated 6/17/25, 5:45 AM